68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma

Clinical trial NCT07774533 · RECRUITING

Trial details

NCT number: NCT07774533
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Osteosarcoma Osteosarcoma, Recurrent, Refractory

Start date: 2026-04-01
Primary completion: 2026-08-05
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.